Optic Neuritis Treatment Trial (ONTT)

NCT00000146 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

NIH

Sponsor class

Conditions

Multiple Sclerosis
Optic Neuritis

Interventions

DRUG: Methylprednisolone
DRUG: Prednisone

Sponsor

National Eye Institute (NEI)